BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement

NEXT STORY
Precision Therapeutics Announces Results of Special Meeting of Stockholders
PREV STORY
Ascendis Pharma Announces Results of Study at ENDO 2019 Evaluating Impact of Hypoparathyroidism on Patient Quality-of-Life
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2

author_avatar
NASDAQ Market News

LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

author_avatar
NASDAQ Market News

GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting

New Results from the IMPACT Study to be Presented at the American Society of ...

author_avatar
NASDAQ Market News